SCHEMBL6934867

SCHEMBL6934867

CC(=O)N1CC(=S)C[C@H]1C(=O)O.CC(=O)Nc1ccc(Oc2ccc(C[C@H](N)C(=O)O)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.39
NPY5R Q15761 5/20 0.38
SLC1A3 P43003 1/20 0.38
SLC1A2 P43004 1/20 0.38
SLC1A1 P43005 1/20 0.38
MMP2 P08253 3/20 0.37
MMP9 P14780 3/20 0.37
HDAC8 Q9BY41 2/20 0.37
MMP1 P03956 1/20 0.37
MMP3 P08254 1/20 0.37
MMP7 P09237 1/20 0.37
MMP8 P22894 1/20 0.37
MMP14 P50281 1/20 0.37
DPP4 P27487 1/20 0.36
DPP8 Q6V1X1 1/20 0.36
DPP7 Q9UHL4 1/20 0.36
PTPN1 P18031 1/20 0.36
NR3C1 P04150 1/20 0.36
TPH1 P17752 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6931449 0.87 ALDH1A1 (0.39) TPH1
SCHEMBL7906163 0.85 L3MBTL1 (0.36) HDAC8
SCHEMBL7905125 0.83 ITGB1 (0.43) PTPN1TPH1
SCHEMBL6932583 0.83 PTPN1 (0.46) DPP4DPP8DPP7PTPN1TPH1
SCHEMBL6930978 0.82 LTA4H (0.46) LTA4HDPP4DPP8DPP7
SCHEMBL7908862 0.82 ALDH1A1 (0.46) TPH1
Phenylalanine SCHEMBL7906184 0.82 SLC7A5 (0.52) SLC1A3SLC1A2SLC1A1HDAC8DPP4
SCHEMBL7896693 0.82 ITGB1 (0.47) TPH1
SCHEMBL7906194 0.82 ITGA4 (0.41) MMP2
SCHEMBL6935180 0.81 DPP4 (0.47) LTA4HDPP4DPP8DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0984981-B1 ANTI-INFLAMMATORY TYROSINE DERIVATIVES CELLTECH THERAPEUTICS LTD (GB) 2003-12-17 EP disclosed
US-6093696-A N-ACETYL-D-THIOPROLINE-(O-2,6-DICHLOROBENZYL)-L-TYROSINE, FOR EXAMPLE; SELECTIVELY INHIBIT THE ALPHA 4 SUBGROUP OF INTEGRINS FROM BINDING TO THEIR LIGANDS; USE IN PROPHYLAXIS OR TREATMENT OF IMMUNE OR INFLAMMATORY DISEASES CELLTECH THERAPEUTICS, LIMITED (GB) 2000-07-25 US disclosed